176 related articles for article (PubMed ID: 8090631)
1. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
[TBL] [Abstract][Full Text] [Related]
2. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
[TBL] [Abstract][Full Text] [Related]
3. Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment.
Bednár J; Nĕmec J; Soutorová M; Neradilová M; Pohunková D; Zamrazil V; Vána S; Havelka J; Röhling S
Endocrinol Exp; 1979 Mar; 13(1):53-63. PubMed ID: 316382
[TBL] [Abstract][Full Text] [Related]
4. [Pursued objectives with the use of 131I for the treatment of hypothyroidism: analysis of 2 series receiving different doses].
Aguayo J; Atria A; Pineda G
Rev Med Chil; 1987 Apr; 115(4):308-13. PubMed ID: 3448739
[No Abstract] [Full Text] [Related]
5. Follicular carcinoma of the thyroid with functioning metastases and clinical hyperthyroidism.
McConnon JK; von Westarp C; Mitchell RI
Can Med Assoc J; 1975 Mar; 112(6):724-5,727. PubMed ID: 1122444
[TBL] [Abstract][Full Text] [Related]
6. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
[No Abstract] [Full Text] [Related]
7. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
[TBL] [Abstract][Full Text] [Related]
8. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
9. [Function of the thyroid gland following radio-iodine therapy in hyperthyroidism: thyroxine, triiodothyronine and TSH reaction after TRH stimulation].
Pickardt CR; Einhäuser G; Erhardt F; Heinze HG; Horn K; Scriba PC
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1874-7. PubMed ID: 829464
[No Abstract] [Full Text] [Related]
10. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease.
Valenta L
Endocrinol Exp; 1971 Jun; 5(3):127-42. PubMed ID: 5005942
[No Abstract] [Full Text] [Related]
12. Serum thyroxine concentrations after radioactive iodine therapy in cats with hyperthyroidism.
Meric SM; Hawkins EC; Washabau RJ; Turrel JM; Feldman EC
J Am Vet Med Assoc; 1986 May; 188(9):1038-40. PubMed ID: 3710887
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine treatment of feline hyperthyroidism in Germany.
Puille M; Knietsch M; Spillmann T; Grünbaum EG; Bauer R
Nuklearmedizin; 2002 Dec; 41(6):245-51. PubMed ID: 12520661
[TBL] [Abstract][Full Text] [Related]
15. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
Seeger T; Emrich D; Sandrock D
Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
Coover LR; Silberstein EB; Kuhn PJ; Graves MW
J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
[TBL] [Abstract][Full Text] [Related]
17. Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer.
Doi SA; Woodhouse NJ
Clin Endocrinol (Oxf); 2000 Jun; 52(6):765-73. PubMed ID: 10848882
[TBL] [Abstract][Full Text] [Related]
18. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
19. [Behavior of serum triiodothyronine in subjects treated with I-131 for hyperthyroidism].
Bagnasco M; Biassoni P; Clemente GF; Vibracci G; Ferrini O
Arch Maragliano Patol Clin; 1975; 31(1):77-87. PubMed ID: 1244069
[No Abstract] [Full Text] [Related]
20. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
